Detalhe da pesquisa
1.
Ketone Supplementation Dampens Subjective and Objective Responses to Alcohol: Evidence From a Preclinical Rat Study and a Randomized, Cross-Over Trial in Healthy Volunteers.
Int J Neuropsychopharmacol
; 27(2)2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38315678
2.
Peripheral and Central Iron Measures in Alcohol Use Disorder and Aging: A Quantitative Susceptibility Mapping Pilot Study.
Int J Mol Sci
; 24(5)2023 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36901892
3.
A randomized, double-blind, placebo-controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder.
Alcohol Clin Exp Res
; 46(10): 1900-1912, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055978
4.
Post-treatment effects of topiramate on alcohol-related outcomes: A combined analysis of two placebo-controlled trials.
Addict Biol
; 27(2): e13130, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35229945
5.
World Health Organization risk drinking levels as a treatment outcome measure in topiramate trials.
Alcohol Clin Exp Res
; 45(8): 1664-1671, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120366
6.
Effects of Recent Alcohol Consumption Level on Neurocognitive Performance in HIV+ Individuals.
Addict Disord Their Treat
; 16(3): 95-107, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29081720
7.
Self-efficacy mediates the effects of topiramate and GRIK1 genotype on drinking.
Addict Biol
; 21(2): 450-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25496338
8.
Smoking and Cellular Telephone Use Among Pregnant Women Seeking Prenatal Care: Opportunities for Intervention.
Addict Disord Their Treat
; 14(4): 203-210, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26755894
9.
Posttreatment effects of topiramate treatment for heavy drinking.
Alcohol Clin Exp Res
; 38(12): 3017-23, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25581656
10.
A GABRA2 variant is associated with increased stimulation and 'high' following alcohol administration.
Alcohol Alcohol
; 49(1): 1-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24166645
11.
An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trial.
Addiction
; 118(6): 1040-1052, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606295
12.
Ketone supplementation dampens subjective and objective responses to alcohol in rats and humans.
bioRxiv
; 2023 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37790364
13.
Pharmacokinetic effects of a single-dose nutritional ketone ester supplement on brain ketone and glucose metabolism in alcohol use disorder - a pilot study.
medRxiv
; 2023 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37808798
14.
Combined analysis of the moderating effect of a GRIK1 polymorphism on the effects of topiramate for treating alcohol use disorder.
Drug Alcohol Depend
; 225: 108762, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049101
15.
Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder.
Neuropsychopharmacology
; 46(8): 1407-1413, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33568796
16.
Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial.
Neuropsychopharmacology
; 46(8): 1414-1420, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33558678
17.
Correction to: Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder.
Neuropsychopharmacology
; 46(8): 1546, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33883700
18.
Topiramate's reduction of body mass index in heavy drinkers: lack of moderation by a GRIK1 polymorphism.
Exp Clin Psychopharmacol
; 22(5): 419-23, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24978347
19.
Dutasteride reduces alcohol's sedative effects in men in a human laboratory setting and reduces drinking in the natural environment.
Psychopharmacology (Berl)
; 231(17): 3609-18, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24557088
20.
Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.
Am J Psychiatry
; 171(4): 445-52, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24525690